VIRxSYS Management and Scientific Team
VIRxSYS has a highly experienced management and scientific team that helped move the Company’s technology from a laboratory at The Johns Hopkins University to the clinic in less than five years.
Management and Team Members
Riku H. Rautsola, PhD – President & CEO
Gary J. McGarrity, PhD – Executive Vice President of Scientific and Clinical Affairs
Gerard F. Fleury, CPA – Executive Vice President & CFO
Laurent Humeau, PhD – Vice President of Research and Development
Shuyuan Zhang, PhD – Vice President of Manufacturing
Tessio Rebello, PhD – Vice President of Clinical Affairs
Yajin Ni, MD, PhD – Director of Developmental Sciences
Franck Lemiale, PhD - Director of Immunobiology
Nikolay Korokhov, PhD - Director of Lentiviral Core Laboratory
Serge Sira, PhD - Intellectual Property Counsel
Board of Directors
Lawrence Michaelis, MD – Chairman
Helmer P. K. Agersborg, Jr., PhD
James V. Kehoe
L. William McIntosh, MBA
John P. Phair, MD
Riku Rautsola, PhD
Franz W. Schmadl, M.Sc.
William N. Sick, Jr. – Co-Founder
William J. Turner, MBA – Co-Founder
Prince K. Zachariah, MD, PhD
"The Board of VIRxSYS is proud of the team that has been assembled within the company. The breadth and depth of these world-class experts in their respective fields is most impressive. These people, and their considerable skills and dedication, have allowed us to move the company's "first-in-class" technology into human clinical trials in the U.S. in less than five years, which is a remarkable accomplishment."
Lawrence L. Michaelis, MD, Chairman of the Board of Directors of VIRxSYS